Unex Remedies Private Limited
Trading and manufacturing of pharmaceutical products, including medicines, healthcare, and dietary supplements.
2013 | Lucknow, Uttar Pradesh (India) | Active
Unex Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 4.51 M
- Revenue Growth -38.71%
- Profit Growth -674.71%
- Ebitda -21.94%
- Net Worth -57.83%
- Total Assets -9.83%
About Unex Remedies
Unex Remedies Private Limited (URPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 June 2013 and has a history of 11 years and eight months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.51 M.
Raghunandan Srivastava and Savita Srivastava serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93030UP2013PTC057925
- Company No.
057925
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2013
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Unex Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savita Srivastava  | Director | 20-Aug-2016 | Current |
| Raghunandan Srivastava | Director | 24-Jun-2013 | Current |
Financial Performance of Unex Remedies.
Unex Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 38.71% decrease. The company also saw a substantial fall in profitability, with a 674.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 57.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unex Remedies?
In 2020, Unex Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹4.51 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2020 | State Bank Of India | ₹4.51 M | Open |
How Many Employees Work at Unex Remedies?
Unlock and access historical data on people associated with Unex Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unex Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unex Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
